Sartorius AG Xetra

SRT

DE0007165607

Advanced Medical Equipment & Technology

Market Closed - Xetra Other stock markets 11:44:17 2024-04-18 am EDT			5-day change	1st Jan Change
209 ^EUR	-15.90%		-20.98%	-21.13%

Apr. 18	German Shares Close Green as Bundesbank Sees Q1 Economic Growth	MT
Apr. 18	SARTORIUS VORZUEGE : Barclays remains Neutral	ZD

Sartorius Aktiengesellschaft Provides Sales Guidance for the Year 2021 and 2025

January 27, 2021 at 01:00 am EST

Sartorius Aktiengesellschaft provided sales guidance for the year 2021 and 2025. Sales revenue set to increase by 19% to 25%- Group management raises sales target for 2025 to about €5 billion.

Latest news about Sartorius AG

German Shares Close Green as Bundesbank Sees Q1 Economic Growth	Apr. 18	MT
SARTORIUS VORZUEGE : Barclays remains Neutral	Apr. 18	ZD
FTSE 100 up despite hawkish Fed rates outlook	Apr. 18	AN
Transcript : Sartorius Aktiengesellschaft, Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Sartorius continues recovery after weak start - share price slide	Apr. 18	DP
SARTORIUS VORZUEGE : Warburg Research reiterates its Neutral rating	Apr. 18	ZD
Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Sartorius and subsidiary Stedim under pressure after weak figures	Apr. 18	DP
SARTORIUS VORZUEGE : Jefferies remains Neutral	Apr. 18	ZD
SARTORIUS VORZUEGE : Berenberg reiterates its Buy rating	Apr. 18	ZD
UBS rates Sartorius 'Neutral' - Target 366 euros	Apr. 18	DP
SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating	Apr. 18	ZD
SARTORIUS VORZUEGE : UBS sticks Neutral	Apr. 18	ZD
Sartorius Posts Lower Q1 Attributable Profit, Sales Revenue	Apr. 18	MT
Sartorius gets off to a slow start to the year - still hoping for recovery	Apr. 18	DP
SARTORIUS VORZUEGE : UBS sticks Neutral	Apr. 17	ZD
Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating	Mar. 28	ZD
Transcript : Sartorius Aktiengesellschaft - Shareholder/Analyst Call	Mar. 28
SARTORIUS VORZUEGE : JP Morgan maintains a Buy rating	Mar. 28	ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral	Mar. 27	ZD
Stifel reinstates Sartorius with 'Buy' - target 415 euros	Mar. 18	DP
SARTORIUS VORZUEGE : UBS reiterates its Neutral rating	Mar. 14	ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral	Mar. 12	ZD

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-15 - Capital Markets Day

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SARTORIUS : FY23: Updated mid-term outlook offers much valued ‘certainty’

January 29, 2024 at 09:04 am EST

More Strategies

Ratings for Sartorius AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

278.9 EUR

Average target price

352.3 EUR

Spread / Average Target

+26.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-48.09%	2.59B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+4.82%	1.61B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-12.79%	1.43B
BIOTAGE AB	+22.29%	1.22B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-14.90%	979M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.61%	880M
REVENIO GROUP OYJ	-9.43%	718M
VAREX IMAGING CORPORATION	-17.46%	687M
CELLAVISION AB	+3.77%	474M

Medical Diagnostic & Testing Equipment

Sartorius AG Xetra

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

Sartorius Aktiengesellschaft Provides Sales Guidance for the Year 2021 and 2025

Latest news about Sartorius AG

Chart Sartorius AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Sartorius AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment